Greenbrook TMS Inc (GBNHF)
OTCMKTS: GBNHF · Delayed Price · USD
0.0711
-0.0149 (-17.33%)
Jul 2, 2024, 3:29 PM EDT - Market closed
Company Description
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States.
Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders.
The company also offers Spravato, an esketamine nasal spray; and other treatment modalities for the treatment of depression and related psychiatric services.
Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Greenbrook TMS Inc
| Country | Ontario, Canada |
| Founded | 2011 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 508 |
Contact Details
Address: 890 Yonge Street, 7th Floor Toronto, A6 M4W 3P4 Ontario, Canada | |
| Phone | 416-322-9700 |
Stock Details
| Ticker Symbol | GBNHF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001735948 |
| SIC Code | 8090 |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 28, 2024 | 8-K | Current Report |
| Jun 28, 2024 | 8-K | Current Report |
| Jun 27, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Jun 27, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Jun 13, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Jun 7, 2024 | 8-K | Current Report |
| Jun 4, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| May 28, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| May 22, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| May 21, 2024 | 8-K | Current Report |